Medical Sciences
Global

Medical Sciences Experts

Steven K. Galson

Senior Vice President,
Global Regulatory Affairs and Safety
Amgen
Canada

Biography

Dr. Steven K. Galson, senior vice president, Global Regulatory Affairs and Safety, joined Amgen in 2010 as vice president, Global Regulatory Affairs. Prior to Amgen, Galson was senior vice president for Civilian Health Operations and chief health scientist at Science Applications International Corporation. Galson spent more than 20 years in government service, including two years as acting Surgeon General of the United States. Previously, he served as director of the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER), where he provided leadership for the center’s broad national and international programs in pharmaceutical regulation. Galson began his Public Health Service (PHS) career as an epidemiological investigator at the Centers for Disease Control and Prevention (CDC) after completing a residency in internal medicine at the Hospitals of the Medical College of Pennsylvania. He also held senior-level positions at the Environmental Protection Agency (EPA); the Department of Energy, where he was a chief medical officer; and the Department of Health and Human Services. Prior to his arrival at the FDA, Galson was director of the EPA’s Office of Science Coordination and Policy, Office of Prevention, Pesticides and Toxic Substances. Galson holds a B.S. from Stony Brook University, an M.D. from Mt. Sinai School of Medicine, and an M.P.H. from the Harvard School of Public Health.  Dr. Steven K. Galson, senior vice president, Global Regulatory Affairs and Safety, joined Amgen in 2010 as vice president, Global Regulatory Affairs. Prior to Amgen, Galson was senior vice president for Civilian Health Operations and chief health scientist at Science Applications International Corporation. Galson spent more than 20 years in government service, including two years as acting Surgeon General of the United States. Previously, he served as director of the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER), where he provided leadership for the center’s broad national and international programs in pharmaceutical regulation. Galson began his Public Health Service (PHS) career as an epidemiological investigator at the Centers for Disease Control and Prevention (CDC) after completing a residency in internal medicine at the Hospitals of the Medical College of Pennsylvania. He also held senior-level positions at the Environmental Protection Agency (EPA); the Department of Energy, where he was a chief medical officer; and the Department of Health and Human Services. Prior to his arrival at the FDA, Galson was director of the EPA’s Office of Science Coordination and Policy, Office of Prevention, Pesticides and Toxic Substances. Galson holds a B.S. from Stony Brook University, an M.D. from Mt. Sinai School of Medicine, and an M.P.H. from the Harvard School of Public Health. 

Research Interest

Medicine

Global Experts from Canada

Global Experts in Subject

Share This Profile
Recommended Conferences